What is Cipher Surgical?
Established in 2010, Cipher Surgical is dedicated to the development and commercialization of its innovative OpClear® technology. The company achieved a significant milestone with a CE mark for a prototype OpClear® in October 2013. Following extensive clinical evaluations and a redesign in 2015 to enhance performance, OpClear® has secured patents and market clearance in Europe and other select regions. Headquartered in Coventry, Cipher Surgical utilizes ISO 13485 accredited manufacturing facilities, which are outsourced within the UK. The company's shares are EIS qualifying, indicating a focus on attracting investment through tax-efficient schemes.
How much funding has Cipher Surgical raised?
Cipher Surgical has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2025): $10M with participation from Medical Solutions
Key Investors in Cipher Surgical
Medical Solutions
Medical Solutions is a healthcare staffing firm that places registered nurses in temporary travel assignments around the nation. Medical Solutions is headquartered in Omaha, Nebraska.
What's next for Cipher Surgical?
The recent major strategic investment of $10M positions Cipher Surgical for accelerated expansion and market development. This capital infusion, part of a larger $10M funding initiative, is expected to fuel further advancements in OpClear® technology and broaden its market reach. The company's focus on securing patents and regulatory clearances, coupled with its ISO-certified manufacturing, provides a strong foundation for scaling operations. Future strategies will likely involve deepening strategic partnerships and enhancing sales channels to capitalize on the growing demand for advanced surgical solutions.
See full Cipher Surgical company page
